World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma tillkännager godkännande för initiering av klinisk studie med Xlucane i USA
Read more >> -
Xbrane Biopharma announces acceptance of initiation of Xlucane clinical trial in the US
Read more >> -
Xbrane Biopharma har lämnat in den första ansökan för start av klinisk studie med Xlucane
Read more >> -
Xbrane Biopharma has submitted the first application for start of Xlucane clinical trial
Read more >> -
Xbrane Biopharma presenterar valberedning
Read more >>
X
